Cubist Systematic Strategies, LLC Viatris Inc Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $228,826 - $274,713	20,304 Added 5640.0%	20,664 $246,000
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $417,671 - $516,731	-47,625 Reduced 99.25%	360 $3,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $460,176 - $544,629	47,985 New	47,985 $473,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $993,020 - $1.32 Million	107,937 Added 53.25%	310,635 $2.99 Million
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $2.86 Million - $3.8 Million	-328,494 Reduced 61.84%	202,698 $2.26 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $1.92 Million - $2.52 Million	226,108 Added 74.11%	531,192 $4.53 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $245,615 - $302,884	24,685 Added 8.8%	305,084 $3.19 Million
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $537,068 - $843,103	-54,747 Reduced 16.34%	280,399 $3.05 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $937,748 - $1.14 Million	-77,564 Reduced 18.79%	335,146 $4.54 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $889,008 - $1.02 Million	-67,095 Reduced 13.98%	412,710 $5.59 Million
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $3.89 Million - $4.85 Million	300,110 Added 167.01%	479,805 $6.86 Million
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $1.33 Million - $1.81 Million	-97,650 Reduced 35.21%	179,695 $2.51 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $3.97 Million - $5.2 Million	277,345 New	277,345 $5.2 Million

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.